2FK-98318-14333
3 vaccinations
0 coded responses
7 check-ins
0 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Dose 1 — Moderna
-
2021-03-12
Dose 2 — Moderna
-
2021-03-13
Registered in v-safe
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-03-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-16
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-03-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-17
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-03-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-26
-
2022-02-02
Dose 3 — Moderna
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Moderna | |
| 2 | 2021-03-12 | Moderna | |
| 3 | 2022-02-02 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-13 | priority 2/3 | |
| 2021-03-15 | priority 2/3 | |
| 2021-03-16 | priority 2/3 | |
| 2021-03-17 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.